METiS Joins the Roche Accelerator

Start-up combines cutting-edge AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations

23-May-2022 - METiS announced officially joining the Roche Accelerator with the goal to tap into Roche’s global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai. "We are excited to become a member ...

Bachem to expand in asian markets

Subsidiary in Tokyo founded

23-Jul-2018 - Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, Chief ...

Merck Invests in its Biotech Manufacturing Site in Bari

New production line for the aseptic filling of biotech medicines under isolator

04-Oct-2017 - Merck will invest €35 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy. The announcement was made as part of an event celebrating the 25th anniversary of the site and its leading role on the science and ...

Evonik is investing in NUMAFERM

Start-up makes the production of peptides more efficient

21-Sep-2017 - Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the spin-off of Heinrich Heine University Düsseldorf. The investment was made as part of a seed financing round and also includes investments by High-Tech Gründerfonds, the Business ...

Lonza Acquires Micro-Macinazione

Swiss company expert in the field of microniziation

07-Aug-2017 - Lonza has acquired Micro-Macinazione, providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased from ...

Acquisition Strenghtens Wacker’s Biologics Activities

14-Nov-2013 - Wacker Biotech GmbH, a subsidiary of Wacker Chemie AG, is acquiring a production site for bioengineered pharmaceutical proteins (biologics) – including the associated business – from BioNet Ventures GmbH. WACKER’s acquisition covers the assets of Scil Proteins Production at the SCIL site in ...

Recipharm announces its intention to acquire Cobra Biomanufacturing

18-Dec-2009 - Recipharm AB announced its intention to acquire Cobra Biomanufacturing plc, a UK-based, cGMP compliant contract manufacturer of biopharmaceuticals. This move will considerably broaden Recipharm’s biologics offering whilst providing access to new markets and technologies including the production ...

Codexis to Establish New R&D Facility in Singapore to Support Expanding Generics Business

28-Aug-2006 - Codexis announced that it will establish a research and development center in Singapore, scheduled to open in the third quarter of 2007. The R&D center will focus on new product development for the company's API and generics business. When fully staffed, the center is expected to house up to 80 ...

Albany Molecular Research, Inc. Breaks Ground On New R&D Centre in India

22-May-2006 - Albany Molecular Research, Inc. announced the construction of a new 50,000 sq. ft. research and development centre at the Shapoorji Pallonji Biotech Park in Hyderabad, India. The company held a groundbreaking ceremony at the site of the new facility, which represents the first major expansion of ...

Lonza continues realization of long-term strategic initiatives

10-May-2006 - Lonza Group announced that the U.S. Food and Drug Administration (FDA) has granted approval for a supplemental Biologics License Application (sBLA) to Bristol-Myers Squibb Company, which includes the licensing of Lonza Biologics Inc. as their third-party manufacturing partner for the active ...